Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Press release

Västra Hamnen Market Focus: Bioextrax: Sweet dreams of a bright 2024

Bioextrax
  • Joint Development Agreement with the candy producer in Q1
  • Progression in several projects, funding risk remains
  • Our model implies a fair valuation of SEK 7.60 per share

A quiet final quarter of 2023 was followed by an eventful start of 2024 for Lund-based Bioextrax. In January, the American startup terminated the contract due to financial issues. For Bioextrax, the financial impact of the cancellation was limited according in our valuation model. However, the stock market reaction on the news was harsh sending the share price down by 30 per cent.

The initial research report is available here.

About Market Focus


The research report is prepared as part of Market Focus, Västra Hamnen Corporate Finance's commissioned research offering.

This is a press release from Västra Hamnen Corporate Finance AB. 
Web: vhcorp.se
Twitter: @vhcorp_se (https://twitter.com/vhcorp_se)

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.